$914.57
16.471.83%
At Close: -
$916.01
1.440.16%
After Hours: Jul 5, 6:27 PM EDT
15 minutes delayed
Eli Lilly and Co
LLYNYSE
want to know what
the Bulls & Bears Say?
Eli Lilly and Co (NYSE:LLY) Stock, Analyst Ratings, Price Targets, Forecasts
Eli Lilly and Co has a consensus price target of $727.04 based on the ratings of 100 analysis. The 3 most-recent analyst ratings were released by Morgan Stanley, BMO Capital, and Cantor Fitzgerald on July 5, 2024, July 3, 2024, and July 1, 2024, respectively. With an average price target of $969.67 between Morgan Stanley, BMO Capital, and Cantor Fitzgerald, there's an implied 5.86% upside for Eli Lilly and Co from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
BMO Capital
Cantor Fitzgerald
Truist Securities
Jefferies
1calculated from analyst ratings
Analyst Ratings for Eli Lilly and Co
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/05/2024 | Buy Now | 11.68% | Morgan Stanley | Terence Flynn | $1023 → $1023 | Maintains | Overweight | Get Alert |
| 07/03/2024 | Buy Now | 9.28% | BMO Capital | Evan Seigerman | $1001 → $1001 | Maintains | Outperform | Get Alert |
| 07/01/2024 | Buy Now | -3.39% | Cantor Fitzgerald | Louise Chen | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/26/2024 | Buy Now | -3.39% | Cantor Fitzgerald | Louise Chen | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/25/2024 | Buy Now | -3.39% | Cantor Fitzgerald | Louise Chen | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/25/2024 | Buy Now | 9.17% | Truist Securities | Srikripa Devarakonda | $892 → $1000 | Reiterates | Buy → Buy | Get Alert |
| 06/24/2024 | Buy Now | 10.81% | Jefferies | Akash Tewari | $994 → $1015 | Maintains | Buy | Get Alert |
| 06/24/2024 | Buy Now | 9.17% | B of A Securities | Geoff Meacham | $1000 → $1000 | Maintains | Buy | Get Alert |
| 06/24/2024 | Buy Now | -3.39% | Cantor Fitzgerald | Louise Chen | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2024 | Buy Now | -3.39% | Cantor Fitzgerald | Louise Chen | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | Buy Now | -3.39% | Cantor Fitzgerald | Louise Chen | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/12/2024 | Buy Now | -3.39% | Cantor Fitzgerald | Louise Chen | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/11/2024 | Buy Now | -3.39% | Cantor Fitzgerald | Louise Chen | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/07/2024 | Buy Now | 4.47% | Jefferies | Akash Tewari | $925 → $957 | Maintains | Buy | Get Alert |
| 05/14/2024 | Buy Now | -8.3% | Argus Research | David Toung | $770 → $840 | Maintains | Buy | Get Alert |
| 05/01/2024 | Buy Now | 9.28% | BMO Capital | Evan Seigerman | $900 → $1001 | Maintains | Outperform | Get Alert |
| 05/01/2024 | Buy Now | -1.75% | JP Morgan | Chris Schott | $850 → $900 | Maintains | Overweight | Get Alert |
| 05/01/2024 | Buy Now | -3.39% | Cantor Fitzgerald | Louise Chen | $815 → $885 | Maintains | Overweight | Get Alert |
| 05/01/2024 | Buy Now | -2.62% | Truist Securities | Srikripa Devarakonda | $850 → $892 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | -3.39% | Cantor Fitzgerald | Louise Chen | $815 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 04/18/2024 | Buy Now | -11.03% | Cantor Fitzgerald | Louise Chen | → $815 | Reiterates | Overweight → Overweight | Get Alert |
| 04/15/2024 | Buy Now | -11.03% | Cantor Fitzgerald | Louise Chen | → $815 | Reiterates | Overweight → Overweight | Get Alert |
| 04/11/2024 | Buy Now | -21.07% | Goldman Sachs | Chris Shibutani | $650 → $723 | Maintains | Neutral | Get Alert |
| 04/05/2024 | Buy Now | -11.03% | Cantor Fitzgerald | Louise Chen | → $815 | Reiterates | Overweight → Overweight | Get Alert |
| 04/03/2024 | Buy Now | — | Erste Group | Hans Engel | — | Upgrade | Hold → Buy | Get Alert |
| 04/02/2024 | Buy Now | -2.29% | Citigroup | Andrew Baum | $675 → $895 | Maintains | Buy | Get Alert |
| 04/01/2024 | Buy Now | -11.03% | Cantor Fitzgerald | Louise Chen | → $815 | Reiterates | Overweight → Overweight | Get Alert |
| 03/22/2024 | Buy Now | -7.21% | Truist Securities | Robyn Karnauskas | → $850 | Reiterates | Buy → Buy | Get Alert |
| 03/15/2024 | Buy Now | -7.21% | JP Morgan | Chris Schott | $775 → $850 | Maintains | Overweight | Get Alert |
| 03/01/2024 | Buy Now | 9.17% | B of A Securities | Geoff Meacham | $800 → $1000 | Maintains | Buy | Get Alert |
| 02/21/2024 | Buy Now | -10.48% | DZ Bank | Elmar Kraus | → $820 | Downgrade | Buy → Hold | Get Alert |
| 02/20/2024 | Buy Now | -11.03% | Cantor Fitzgerald | Louise Chen | → $815 | Reiterates | Overweight → Overweight | Get Alert |
| 02/16/2024 | Buy Now | 3.71% | Morgan Stanley | Terence Flynn | $805 → $950 | Maintains | Overweight | Get Alert |
| 02/14/2024 | Buy Now | -11.03% | Cantor Fitzgerald | Louise Chen | → $815 | Reiterates | Overweight → Overweight | Get Alert |
| 02/07/2024 | Buy Now | -7.21% | Truist Securities | Robyn Karnauskas | $650 → $850 | Maintains | Buy | Get Alert |
| 02/07/2024 | Buy Now | -12.12% | Morgan Stanley | David Phung | $763 → $805 | Maintains | Overweight | Get Alert |
| 02/07/2024 | Buy Now | -11.57% | Barclays | Geoff Meacham | $680 → $810 | Maintains | Overweight | Get Alert |
| 02/07/2024 | Buy Now | -9.94% | Wells Fargo | Mohit Bansal | $700 → $825 | Maintains | Overweight | Get Alert |
| 02/07/2024 | Buy Now | -5.57% | BMO Capital | Evan Seigerman | $710 → $865 | Maintains | Outperform | Get Alert |
| 02/06/2024 | Buy Now | -9.94% | Wells Fargo | Mohit Bansal | $700 → $825 | Maintains | Overweight | Get Alert |
| 02/06/2024 | Buy Now | -11.03% | Cantor Fitzgerald | Louise Chen | $630 → $815 | Maintains | Overweight | Get Alert |
| 02/05/2024 | Buy Now | -31.22% | Cantor Fitzgerald | Louise Chen | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 02/01/2024 | Buy Now | -31.22% | Cantor Fitzgerald | Louise Chen | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 01/24/2024 | Buy Now | -23.58% | Wells Fargo | Mohit Bansal | $650 → $700 | Maintains | Overweight | Get Alert |
| 01/23/2024 | Buy Now | -31.22% | Cantor Fitzgerald | Louise Chen | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 01/23/2024 | Buy Now | -25.77% | Barclays | Carter Gould | $630 → $680 | Maintains | Overweight | Get Alert |
| 12/21/2023 | Buy Now | -33.41% | Daiwa Capital | Eli Lilly | → $610 | Downgrade | Buy → Outperform | Get Alert |
| 11/29/2023 | Buy Now | -29.04% | Truist Securities | Robyn Karnauskas | → $650 | Reiterates | Buy → Buy | Get Alert |
| 11/20/2023 | Buy Now | -31.22% | Cantor Fitzgerald | Louise Chen | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 11/17/2023 | Buy Now | -31.22% | Cantor Fitzgerald | Louise Chen | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 11/15/2023 | Buy Now | -31.22% | Cantor Fitzgerald | Louise Chen | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 11/09/2023 | Buy Now | -41.59% | Deutsche Bank | James Shin | → $535 | Initiates | → Hold | Get Alert |
| 11/08/2023 | Buy Now | — | JP Morgan | Chris Schott | — | Reiterates | → Overweight | Get Alert |
| 11/03/2023 | Buy Now | -21.18% | Morgan Stanley | David Phung | $673 → $722 | Maintains | Overweight | Get Alert |
| 10/23/2023 | Buy Now | -26.31% | Citigroup | Andrew Baum | $525 → $675 | Maintains | Buy | Get Alert |
| 10/23/2023 | Buy Now | -31.22% | Cantor Fitzgerald | Louise Chen | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 10/20/2023 | Buy Now | -22.49% | UBS | Trung Huynh | $612 → $710 | Assumes | Buy → Buy | Get Alert |
| 10/11/2023 | Buy Now | -26.53% | Morgan Stanley | David Phung | $640 → $673 | Maintains | Overweight | Get Alert |
| 10/09/2023 | Buy Now | -31.22% | Cantor Fitzgerald | Louise Chen | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 10/09/2023 | Buy Now | -29.04% | Wells Fargo | Mohit Bansal | $615 → $650 | Maintains | Overweight | Get Alert |
| 10/02/2023 | Buy Now | -31.22% | Cantor Fitzgerald | Louise Chen | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2023 | Buy Now | -32.32% | Argus Research | David Toung | $470 → $620 | Maintains | Buy | Get Alert |
| 09/05/2023 | Buy Now | -30.13% | Morgan Stanley | David Phung | $617 → $640 | Maintains | Overweight | Get Alert |
| 09/05/2023 | Buy Now | -31.22% | Cantor Fitzgerald | Louise Chen | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | Buy Now | -31.22% | Cantor Fitzgerald | Louise Chen | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 08/10/2023 | Buy Now | -48.69% | Goldman Sachs | Chris Shibutani | $385 → $470 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | -39.96% | Cantor Fitzgerald | Louise Chen | → $550 | Reiterates | Overweight → Overweight | Get Alert |
| 08/09/2023 | Buy Now | -34.5% | JP Morgan | Chris Schott | $510 → $600 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | -35.59% | Barclays | Carter Gould | $500 → $590 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | -48.69% | Goldman Sachs | Chris Shibutani | $385 → $470 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | -30.9% | BMO Capital | Evan Seigerman | $565 → $633 | Maintains | Outperform | Get Alert |
| 08/09/2023 | Buy Now | -34.5% | Truist Securities | Robyn Karnauskas | $525 → $600 | Maintains | Buy | Get Alert |
| 08/09/2023 | Buy Now | -36.68% | Credit Suisse | Trung Huynh | $490 → $580 | Maintains | Outperform | Get Alert |
| 08/09/2023 | Buy Now | -32.64% | Morgan Stanley | David Phung | $560 → $617 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | -36.68% | RBC Capital | Trung Huynh | $490 → $580 | Maintains | Outperform | Get Alert |
| 08/09/2023 | Buy Now | -32.86% | Jefferies | Akash Tewari | → $615 | Upgrade | Hold → Buy | Get Alert |
| 08/08/2023 | Buy Now | -32.86% | Wells Fargo | Mohit Bansal | $500 → $615 | Maintains | Overweight | Get Alert |
| 07/28/2023 | Buy Now | -44.32% | JP Morgan | Chris Schott | $475 → $510 | Maintains | Overweight | Get Alert |
| 07/26/2023 | Buy Now | -42.69% | Citigroup | Andrew Baum | $360 → $525 | Maintains | Buy | Get Alert |
| 07/21/2023 | Buy Now | -53.06% | Jefferies | Akash Tewari | $408 → $430 | Maintains | Hold | Get Alert |
| 07/21/2023 | Buy Now | -38.87% | Morgan Stanley | David Phung | $551 → $560 | Maintains | Overweight | Get Alert |
| 07/20/2023 | Buy Now | -42.69% | Truist Securities | Gregg Gilbert | $430 → $525 | Maintains | Buy | Get Alert |
| 07/17/2023 | Buy Now | -39.96% | Cantor Fitzgerald | Louise Chen | → $550 | Reiterates | Overweight → Overweight | Get Alert |
| 07/14/2023 | Buy Now | -38.87% | HSBC | Rajesh Kumar | → $560 | Initiates | → Buy | Get Alert |
| 07/13/2023 | Buy Now | -39.96% | Cantor Fitzgerald | Louise Chen | → $550 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | Buy Now | -39.85% | Morgan Stanley | David Phung | $507 → $551 | Maintains | Overweight | Get Alert |
| 06/27/2023 | Buy Now | -39.96% | Cantor Fitzgerald | Louise Chen | $485 → $550 | Maintains | Overweight | Get Alert |
| 06/27/2023 | Buy Now | -53.06% | Truist Securities | Gregg Gilbert | → $430 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | Buy Now | -47.05% | Cantor Fitzgerald | Louise Chen | → $485 | Reiterates | Overweight → Overweight | Get Alert |
| 05/26/2023 | Buy Now | -47.05% | Cantor Fitzgerald | Louise Chen | → $485 | Reiterates | Overweight → Overweight | Get Alert |
| 05/26/2023 | Buy Now | -45.42% | Wells Fargo | Mohit Bansal | $440 → $500 | Maintains | Overweight | Get Alert |
| 05/24/2023 | Buy Now | -45.42% | B of A Securities | Jason Gerberry | $450 → $500 | Maintains | Buy | Get Alert |
| 05/23/2023 | Buy Now | -45.42% | TD Cowen | Steve Scala | $430 → $500 | Maintains | Outperform | Get Alert |
| 05/22/2023 | Buy Now | -47.05% | Cantor Fitzgerald | Louise Chen | $485 → $485 | Reiterates | Overweight → Overweight | Get Alert |
| 05/15/2023 | Buy Now | -44.65% | Morgan Stanley | David Phung | $478 → $507 | Maintains | Overweight | Get Alert |
| 05/04/2023 | Buy Now | -44.87% | BMO Capital | Evan Seigerman | $430 → $505 | Maintains | Outperform | Get Alert |
| 05/04/2023 | Buy Now | -48.14% | JP Morgan | Chris Schott | $430 → $475 | Maintains | Overweight | Get Alert |
| 05/04/2023 | Buy Now | -46.51% | Credit Suisse | Trung Huynh | $420 → $490 | Maintains | Outperform | Get Alert |
| 05/01/2023 | Buy Now | -50% | SVB Securities | David Risinger | $410 → $458 | Maintains | Outperform | Get Alert |
| 05/01/2023 | Buy Now | -54.15% | Barclays | Carter Gould | $400 → $420 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Eli Lilly and Co (LLY) stock?
The latest price target for Eli Lilly and Co (NYSE:LLY) was reported by Morgan Stanley on July 5, 2024. The analyst firm set a price target for $1023.00 expecting LLY to rise to within 12 months (a possible 11.68% upside). 86 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Eli Lilly and Co (LLY)?
The latest analyst rating for Eli Lilly and Co (NYSE:LLY) was provided by Morgan Stanley, and Eli Lilly and Co maintained their overweight rating.
When was the last upgrade for Eli Lilly and Co (LLY)?
The last upgrade for Eli Lilly and Co happened on April 3, 2024 when Erste Group raised their price target to N/A. Erste Group previously had a hold for Eli Lilly and Co.
When was the last downgrade for Eli Lilly and Co (LLY)?
The last downgrade for Eli Lilly and Co happened on February 21, 2024 when DZ Bank changed their price target from N/A to $820 for Eli Lilly and Co.
When is the next analyst rating going to be posted or updated for Eli Lilly and Co (LLY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eli Lilly and Co, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eli Lilly and Co was filed on July 5, 2024 so you should expect the next rating to be made available sometime around July 5, 2025.
Is the Analyst Rating Eli Lilly and Co (LLY) correct?
While ratings are subjective and will change, the latest Eli Lilly and Co (LLY) rating was a maintained with a price target of $1023.00 to $1023.00. The current price Eli Lilly and Co (LLY) is trading at is $916.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.